Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial

Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-21T14:23:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T14:00:30.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    - Access to the study record is blocked by a 403 Forbidden page, replacing the detailed study information with an error screen. The change removes visible study details, including the study description, contacts, and locations, preventing user access to enrollment and background information.
    Difference
    20%
    Check dated 2026-09-23T19:22:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    UI copy changed from 'Find Contact Information' to 'Find contact information', and the revision label updated to v3.7.0 (replacing v3.6.6).
    Difference
    0.1%
    Check dated 2026-09-16T22:05:37.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page underwent a minor software revision, updating from v3.6.5 to v3.6.6. This update generally reflects backend or UI improvements without altering study content.
    Difference
    0.0%
    Check dated 2026-09-02T20:07:39.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now lists the Study Contact and Investigator details with direct contact information (jen.olson@alleviantmedical.com, +1 612 327 2741) and names of multiple investigators and sites. The recruitment status is shown as Recruiting with an updated 93-location site count, and several previously listed locations and the 'Enrolling by invitation' status were removed.
    Difference
    14%
    Check dated 2026-08-19T13:18:20.000Z thumbnail image

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.